Previously submitted to: JMIR Medical Informatics (no longer under consideration since Jun 10, 2024)
Date Submitted: Apr 4, 2024
Open Peer Review Period: Apr 4, 2024 - May 30, 2024
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Machine learning-based model stacking and multi-key biomarker association for rapid differentiation of patients with acute chest pain：a multicenter study with subgroup bias evaluation
ABSTRACT
Despite significant advancements in cardiovascular disease research, the rapid diagnosis of acute high-risk chest pain diseases such as acute myocardial infarction (AMI), pulmonary embolism (PE), and aortic dissection (AD) remains a challenge in the emergency setting. We developed a multicenter risk prediction model (Stacking-Optuna) that rapidly and accurately distinguishes between AMI, PE, and AD. This model underscores the importance of biomarkers such as cardiac troponin, brain natriuretic peptide, and D-dimer while addressing the limitations of current diagnostic methods, especially in terms of considering patient age, gender, and the combined use of different indicators. This model integrates three large-scale databases for training and validation. The results demonstrate that Stacking-Optuna exhibits exceptional discriminative ability for all three acute chest pain diseases (AMI group: AUC=0.9380 [95%CI 0.9160-0.9480], PE group: AUC=0.9480 [95%CI 0.9220-0.9560], AD group: AUC=0.9540 [95%CI 0.9260-0.9640]). Additionally, the interpretability analysis and bias evaluation further reveal the model's consistency and generalizability in a clinical context (the median AUC of bias evaluations covering fifteen subgroups were above 0.83). This clinical knowledge-based fusion and data-driven approach supports rapid and accurate risk assessment of patients with emergency chest pain in the ICU, providing a more effective diagnostic tool for patients with cardiovascular emergencies.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.